NCT06272448Completed
teleRehabilitation for pAtients With ParkInson's Disease at Any mOment
Source: ClinicalTrials.gov · Last updated 22 Nov 2024
Brief summary (registry, in English)
The goal of this clinical trial is to test the feasibility and safety of a telerehabilitation and telemonitoring approach in people with Parkinson's disease at any stage. The main questions it aims to answer are: will patients with Parkinson's disease comply with the recommended level of training at home using an ad hoc developed telerehabilitation platform? • Will this training be safe and impact the patient's well-being perception? Participants will be given a tablet and instructed to access an online platform to observe different motor tasks presented in as many video clips by experienced therapists.They will be requested to perform the motor tasks per a predetermined protocol over 3 months. Their compliance with the recommended training will be checked by physiotherapists every 15 days during phone calls, whereas their daily level of motor activity will be recorded by a smartwatch.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 103 (actual)
- First submitted
- 16 Jan 2023
- Start date
- 15 Nov 2022
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Università Politecnica delle Marche
- Diseases
- Parkinson disease
- NCT number
- NCT06272448
What you commit to
- Study type: Interventional
- Participants enrolled: 103
- From 15 Nov 2022 to the primary completion date, 1 Oct 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- expected need for adapting antiparkinsonian drug regimen over a 6 month period.
Other illness
- moderate-severe cognitive impairment (MoCA≤18)
- comorbidities with adverse impact on functioning or survival or affecting the performance of physical exercise (e.g. serious neoplastic diseases, cardiovascular diseases not controlled pharmacologically including arterial hypertension or hypotension, cardiac arrhythmias, heart failure, musculoskeletal diseases, dizziness or vertigo);
- severe depression or other neuropsychiatric disorders;
Other
- any other factor known to interfere with the ability to interact with the telerehabilitation platform (e.g. poor visual acuity, lack of family support);
Who the study is looking for
- Diagnosis of Parkinson's disease (according to Movement Disorder Society criteria)
- Ability to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Neurorehabilitation Clinic Coordinator of this site? Confirm its status | Ancona | Italy | Unknown status |
| Università di Verona Coordinator of this site? Confirm its status | Verona | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.